Log In
BCIQ
Print this Print this
 

DermX

  Manage Alerts
Collapse Summary General Information
Company ProCertus BioPharm Inc.
DescriptionTopical norepinephrine bitartrate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationDermatitis
Indication DetailsPrevent radiodermatitis in breast cancer patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today